Introduction
Enterococcus is a gram-positive, non-sporing, facultative anaerobe. It is a common cause of nosocomial
infections in the United States. Enterococcal bacteremia is primarily a nosocomial infection in the medical
intensive care unit (ICU), with a preference for elderly patients with multiple comorbidities.
Material and methods
This is a retrospective cohort study using the publicly accessible National (Nationwide) Inpatient Sample
(NIS) database from October 2015 to December 2017. We examined data from 75,430 patients aged 18 years
and older in the NIS who developed enterococcal bacteremia, as identified from the ICD-10 CM codes (B95),
to discuss the epidemiologic effects and outcomes of enterococcal bacteremia. Patients were classified based
on demographics, and comorbidities were identified. Three primary outcomes were studied: in-hospital
mortality, length of stay, and healthcare cost. The secondary outcome was identifying any comorbidities
associated with enterococcal bacteremia. Length of stay was defined as days from admission to discharge or
death. Healthcare costs were estimated from the hospital perspective from hospital-level ratios of costs-tocharges. SAS 9.4 (2013; SAS Institute Inc., Cary, North Carolina, United States) was used for univariate and
multivariate analyses. For data analysis, mortality was modeled using logistic regression. Length of stay and
costs were modeled using linear regression, controlling for patient and hospital characteristics. Statistical
analyses were performed using SAS. Statistical significance was defined as P<0.05.
Results
A total of 75,430 patients with enterococcal bacteremia were included in the study. Of this, 44,270 were
males and 31,160 females. A total of 50,270 (68.67%) were Caucasians, 11,210 (15.31%) were African
Americans, 6,445 (8.80%) were Hispanic and 2,025 (2.77%) were native Americans. Important comorbidities
were congestive heart failure (25.91%), valvular disease (8.08%), neurological complications (11.87%),
diabetes mellitus with complications (18.89%), renal failure (28.52%), and obesity (11.61%). In-hospital
mortality was 11.07%, length of stay was 13.8 days, and a healthcare cost of 41,232.6 USD.
Conclusions
Enterococcal bacteremia is a nosocomial infection with a preference for the elderly with renal failure,
cardiac failure, cardiac valvular diseases, stroke, obesity, and diabetes with complications. Further studies
are needed to see whether the mortality caused by enterococcal bacteremia is attributable to comorbidities
or to the bacteremia. It is associated with a more extended hospital stay and higher healthcare expenditure.
Implementing contact precautions to contain the spread of methicillin-resistant Staphylococcus aureus
(MRSA) and vancomycin-resistant Enterococcus (VRE) has also checked the spread of enterococci. Further
prospective studies can be planned using chart-based data.